Nalu Medical, Inc. Overview
Pro stress-test →Nalu Medical is a privately held medical device company based in Carlsbad, California that has developed the Nalu neurostimulation system, a battery-free, micro-implantable pulse generator currently FDA-cleared for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The micro-implant delivers treatment capabilities similar to larger systems while offering advanced waveforms, extensive programming options, exceptional upgradability, and an expected service life of 18 years.
Strategic Profile
Pro stress-test →Boston Scientific entered into a definitive agreement to acquire Nalu Medical in October 2025 for approximately $533 million upfront for remaining equity not owned by Boston Scientific, which has been a strategic investor since 2017. The company addresses a significant unmet need in chronic neuropathic pain management with a miniaturized, wirelessly-powered implant that differentiates it from larger legacy neurostimulation devices.
Competitive Landscape
Pro stress-test →Nalu competes in the neurostimulation market against established players like Medtronic, Abbott, and Boston Scientific's existing portfolio, as well as emerging neuromodulation companies. The company's key differentiation is miniaturization and wireless power architecture, enabling better patient acceptance and implant longevity compared to larger, battery-dependent traditional systems.
Industry Context
Nalu Medical, Inc. operates in Neurostimulation implants and systems.
Key facts
Headquarters: Carlsbad, California, US · Employees: 252 (April 2026) · Revenue: $4M (2025)